Following the release of Netflix’s Painkiller, the Sackler family’s net worth in 2024 has become a subject of curiosity. Once ...
Mortimer and Raymond Sackler are the late patriarchs of a family under fire now for its central role in the opioid addiction crisis, which has led to hundreds of thousands of American deaths.
The Justice Department argued that shielding the… OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family ...
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...
The notorious Sackler family, opioid pushers responsible for countless cases of addiction and death, can’t seem to settle their legal problems without turning to some kind of unprincipled maneuver.
NEW YORK, Feb 25 (Reuters) - Purdue Pharma told a U.S. bankruptcy judge on Tuesday that it will finalize a new bankruptcy plan in March, with the company's Sackler family owners potentially paying ...
Purdue Pharma and its controlling Sackler family have offered a new settlement to resolve lawsuits over their involvement in the opioid epidemic, raising the payout from the Sacklers to $6 billion.
The move is part of a tentative settlement of $12 billion to settle myriad lawsuits connected to the company’s marketing of opioid painkillers. (JTA) — The Sackler family-owned Purdue Pharma ...
29,097 people played the daily Crossword recently. Can you solve it faster than others?29,097 people played the daily Crossword recently. Can you solve it faster than others? I was in the packed ...
10/10 The Sackler family's reputation comes under intense scrutiny around the world.
Purdue Pharma, the makers and marketers of the highly addictive opioid OxyContin, and the family that owned the company, the Sackler family, have agreed to pay $7.4 billion to individuals ...
Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an ...